Indrayani Biotech Closes Trading Window for Q2 FY27

Indrayani Biotech Ltd has announced the closure of its trading window for directors, designated persons, and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and will be effective from October 01, 2026, until 48 hours after the declaration of the unaudited financial statements for the quarter and half-year ending September 30, 2026. The company has also updated this information on the NSDL portal to restrict trading by designated persons by freezing PAN at the security level. The exact date for the board meeting to declare these financial results will be intimated later.